Best Nassau County Grants for Nonprofits in New York

The Pathway to Stop Diabetes Initiator Award (INI) aims to support early career researchers in diabetes research by providing funding and mentorship. With a focus on innovative and transformational ideas, this initiative encourages researchers to develop groundbreaking solutions for diabetes prevention and management. The award offers up to $100,000 annually in Phase 1 and $325,000 in Phase 2, fostering a new generation of leaders committed to improving the lives of those affected by diabetes.

The Pathway to Stop Diabetes Accelerator Award supports innovative early-career researchers tackling diabetes-related challenges. It offers flexible funding up to $325,000 annually for transformative research. Candidates must have independent faculty status and demonstrated productivity in diabetes research. The program aims to inspire groundbreaking discoveries by providing essential resources and mentorship, thereby improving the lives of those affected by diabetes. Nominations focus on translational research that bridges basic science with practical benefits for patients.

The National Forest Foundation’s Collaborative Capacity Program offers financial awards to enhance collaboration among communities, tribes, and the Forest Service. Aimed at improving wildfire resilience and forest health, these grants support efforts that lead to long-term stewardship outcomes. Funding ranges from $10,001 to $75,000, with a 20% match required. The program seeks to empower local partners to develop strategic plans and strengthen collaborative initiatives, ultimately benefiting National Forest System lands.

The National Forest Foundation’s Collaborative Capacity Program offers financial support to enhance collaboration among local communities and partners, focusing on improving wildfire resilience and forest health. Grants range from $10,001 to $75,000, with a 20% cash or in-kind match requirement. The program aims to foster long-term stewardship outcomes for National Forest System lands, ensuring benefits to both forests and local economies through collaborative efforts.

The Forecast for Clinical Trial Readiness for Rare Diseases (R21) aims to enhance the development and testing of diagnostics and therapeutics for rare diseases. This funding opportunity invites researchers to facilitate clinical trial readiness by developing rigorous biomarkers and clinical outcome measures. Through collaborative efforts with various stakeholders, NCATS seeks to improve the efficiency of moving candidate therapeutics towards clinical trials, ultimately increasing the likelihood of successful treatments for rare diseases.